5 completed, 1 unknown. 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Unknown 1 |
| Phase 2 | 4 | Completed 3, Unknown 1 |
Follow verubulin: new trials by email Literature Review of verubulin trials Research Report on verubulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme Verubulin, Temozolomide & Radiation Therapy - Glioblastoma Multiforme | Phase 2 | Completed | Myrexis Inc. | 5 | 2010-12-01 | 2012-04-11 |
| Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme Azixa - Glioblastoma Multiforme | Phase 2 | Completed | Myrexis Inc. | 56 | 2009-04-01 | 2011-10-14 |
| Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma MPC-6827 + Temozolomide - Metastatic Melanoma | Phase 1 / Phase 2 | Completed | Myrexis Inc. | 22 | 2008-03-01 | 2010-08-23 |
| Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme MPC-6827 + Carboplatin - Glioblastoma Multiforme | Phase 1 / Phase 2 | Unknown | Myrexis Inc. | 30 | 2008-03-01 | 2011-03-25 |
| Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain Metastases MPC-6827 - Brain Neoplasms | Phase 1 | Completed | Myrexis Inc. | 18 | 2005-12-01 | 2008-02-13 |
| Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors MPC-6827 - Refractory Solid Tumors | Phase 1 | Completed | Myrexis Inc. | 48 | 2005-03-01 | 2008-02-13 |
Brain Neoplasms (3) · Glioblastoma (3) · Neoplasm Metastasis (2) · Recurrence (2) · Melanoma (1)
Myrexis Inc. (6)
United States (6)
Andrew Beelen, MD (2) · Andrew P. Beelen, MD (2) · Margaret Yu, MD (2) · Lawrence Recht, MD (1)